NICE Recommends Genedrive Test in Draft Guidance to Prevent Hearing Loss in Newborns
NICE recommended that Genedrive's MT-RNR1 ID Kit should be adopted by the NHS for the prevention of antibiotic-induced hearing loss.
UK's NICE to Accelerate Assessment of Genedrive Test
NICE plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via a new program.
The assay and point-of-care device were implemented in a trial in cooperation with clinical partners based at Manchester University NHS Foundation Trust.
Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays
The Manchester, UK-based company had previously planned to have a CE-IVD marked test out by June 30.
Invitae, Decibel Therapeutics Launch Free Testing Program for Congenital Hearing Loss
Qualifying children will have free access to Invitae's Comprehensive Deafness Panel, which assesses multiple genes linked to syndromic and non-syndromic deafness.
Aug 23, 2019
Jun 12, 2019
Apr 11, 2018